Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-10-042015
Filing Date
2010-04-30
Accepted
2010-04-30 17:04:49
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A c99972e10vkza.htm 10-K/A 231849
2 EXHIBIT 21.1 c99972exv21w1.htm EX-21.1 1815
3 EXHIBIT 31.1 c99972exv31w1.htm EX-31.1 6138
4 EXHIBIT 31.2 c99972exv31w2.htm EX-31.2 6148
5 EXHIBIT 32.1 c99972exv32w1.htm EX-32.1 4448
6 EXHIBIT 32.2 c99972exv32w2.htm EX-32.2 4436
  Complete submission text file 0000950123-10-042015.txt   256585
Mailing Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 415-283-2200
VIA Pharmaceuticals, Inc. (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27264 | Film No.: 10788571
SIC: 2836 Biological Products, (No Diagnostic Substances)